| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ... Nature medicine 10 (9), 942-949, 2004 | 6256 | 2004 |
| Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity TJ Curiel, S Wei, H Dong, X Alvarez, P Cheng, P Mottram, R Krzysiek, ... Nature medicine 9 (5), 562-567, 2003 | 1540 | 2003 |
| Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor J Alam, C Wicks, D Stewart, P Gong, C Touchard, S Otterbein, AMK Choi, ... Journal of Biological Chemistry 275 (36), 27694-27702, 2000 | 517 | 2000 |
| Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor GS Ashcroft, SJ Mills, KJ Lei, L Gibbons, MJ Jeong, M Taniguchi, M Burow, ... The Journal of clinical investigation 111 (9), 1309-1318, 2003 | 447 | 2003 |
| Pesticides reduce symbiotic efficiency of nitrogen-fixing rhizobia and host plants JE Fox, J Gulledge, E Engelhaupt, ME Burow, JA McLachlan Proceedings of the National Academy of Sciences 104 (24), 10282-10287, 2007 | 428 | 2007 |
| MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways X Rao, G Di Leva, M Li, F Fang, C Devlin, C Hartman-Frey, ME Burow, ... Oncogene 30 (9), 1082-1097, 2011 | 418 | 2011 |
| Evaluation of the estrogenic effects of legume extracts containing phytoestrogens SM Boué, TE Wiese, S Nehls, ME Burow, S Elliott, CH Carter-Wientjes, ... Journal of agricultural and food chemistry 51 (8), 2193-2199, 2003 | 379 | 2003 |
| Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system R Simstein, M Burow, A Parker, C Weldon, B Beckman Experimental biology and medicine 228 (9), 995-1003, 2003 | 378 | 2003 |
| The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone CC Williams, JG Allison, GA Vidal, ME Burow, BS Beckman, L Marrero, ... The Journal of cell biology 167 (3), 469-478, 2004 | 304 | 2004 |
| Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat CR Tate, LV Rhodes, HC Segar, JL Driver, FN Pounder, ME Burow, ... Breast Cancer Research 14, 1-15, 2012 | 298 | 2012 |
| Differences in susceptibility to tumor necrosis factor α-induced apoptosis among MCF-7 breast cancer cell variants ME Burow, CB Weldon, Y Tang, GL Navar, S Krajewski, JC Reed, ... Cancer research 58 (21), 4940-4946, 1998 | 263 | 1998 |
| MEK5/ERK5 pathway: the first fifteen years BA Drew, ME Burow, BS Beckman Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1825 (1), 37-48, 2012 | 239 | 2012 |
| Targeting CXCL12/CXCR4 axis in tumor immunotherapy W Zhou, S Guo, M Liu, ME Burow, G Wang Current medicinal chemistry 26 (17), 3026-3041, 2019 | 206 | 2019 |
| Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway L Mao, L Yuan, LM Slakey, FE Jones, ME Burow, SM Hill Breast Cancer Research 12, 1-14, 2010 | 200 | 2010 |
| Estrogenic and antiestrogenic activities of flavonoidphytochemicals through estrogen receptorbinding-dependent and-independent mechanisms BM Collins-Burow, ME Burow, BN Duong, JA McLachlan Nutrition and cancer 38 (2), 229-244, 2000 | 190 | 2000 |
| Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers AL Strong, JF Ohlstein, BA Biagas, LV Rhodes, DT Pei, HA Tucker, ... Breast Cancer Research 17, 1-16, 2015 | 188 | 2015 |
| Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors DM Cittelly, PM Das, VA Salvo, JP Fonseca, ME Burow, FE Jones Carcinogenesis 31 (12), 2049-2057, 2010 | 188 | 2010 |
| Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy MJ Strong, G Xu, J Coco, C Baribault, DS Vinay, MR Lacey, AL Strong, ... PLoS pathogens 9 (5), e1003341, 2013 | 181 | 2013 |
| Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer LV Rhodes, SP Short, NF Neel, VA Salvo, Y Zhu, S Elliott, Y Wei, D Yu, ... Cancer research 71 (2), 603-613, 2011 | 179 | 2011 |
| Endocrine disruptor regulation of microRNA expression in breast carcinoma cells SL Tilghman, MR Bratton, HC Segar, EC Martin, LV Rhodes, M Li, ... PloS one 7 (3), e32754, 2012 | 178 | 2012 |
Lyndsay RhodesFlorida Gulf Coast UniversityVerified email at fgcu.edu
